AnnKatrin Petersen

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

William J. Sandborn, Brian G. Feagan, Geert D’Haens et al. · New England Journal of Medicine · 2021 · 503 citations · Full text

Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study

William J. Sandborn, Brian G. Feagan, Stephen B. Hanauer et al. · Journal of Crohn s and Colitis · 2021 · 104 citations · Full text

Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension

Silvio Danese, Remo Panaccione, María T. Abreu et al. · Journal of Crohn s and Colitis · 2023 · 39 citations · Full text

Targeting of Rifamycin SV to the Colon for Treatment of Travelers' Diarrhea: A Randomized, Double‐Blind, Placebo‐Controlled Phase 3 Study

Herbert L. DuPont, AnnKatrin Petersen, Jeff Zhao et al. · Journal of Travel Medicine · 2014 · 24 citations

Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension Analyses

Alessandro Armuzzi, Raymond Cross, Gary R. Lichtenstein et al. · Clinical Gastroenterology and Hepatology · 2023 · 18 citations · Full text